{"transactions":[{"id":992647,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T16:02:03.000Z","date":"2025-11-18","kind":"other","planned":false,"acquired":false,"shares":2500000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":5444207,"source":{"system":"sec-edgar","filing":"0001213900-25-113113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025113113/ownership.xml","form_type":"4"}},{"id":992646,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T16:02:03.000Z","date":"2025-11-18","kind":"other","planned":false,"acquired":true,"shares":11818,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":7944207,"source":{"system":"sec-edgar","filing":"0001213900-25-113113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025113113/ownership.xml","form_type":"4"}},{"id":992645,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T16:02:03.000Z","date":"2025-11-18","kind":"other","planned":false,"acquired":false,"shares":590892,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were held by TOI M, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-25-113113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025113113/ownership.xml","form_type":"4"}},{"id":1046927,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T06:12:18.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":681832,"price":3.09,"value":2106860.88,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by TOI M, LLC."}],"balance_after":590892,"source":{"system":"sec-edgar","filing":"0001213900-25-084700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025084700/ownership.xml","form_type":"4"}},{"id":1046926,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T06:12:18.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":6018168,"price":3.09,"value":18596139.12,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"M33 Growth I GP LLC (\"M33 LLC\") is the general partner of M33 Growth I L.P. (\"M33 LP\") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":7932389,"source":{"system":"sec-edgar","filing":"0001213900-25-084700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025084700/ownership.xml","form_type":"4"}},{"id":1118224,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T16:15:23.000Z","date":"2025-06-05","kind":"sale","planned":false,"acquired":false,"shares":76324,"price":3.05,"value":232788.2,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by TOI M, LLC."}],"balance_after":1272724,"source":{"system":"sec-edgar","filing":"0001213900-25-052626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025052626/ownership.xml","form_type":"4"}},{"id":1118223,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T16:15:23.000Z","date":"2025-06-05","kind":"sale","planned":false,"acquired":false,"shares":673676,"price":3.05,"value":2054711.8,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"M33 Growth I GP LLC (\"M33 LLC\") is the general partner of M33 Growth I L.P. (\"M33 LP\") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":13950557,"source":{"system":"sec-edgar","filing":"0001213900-25-052626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025052626/ownership.xml","form_type":"4"}},{"id":1137479,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T19:38:56.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":203532,"price":2.7129,"value":552161.9628,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by TOI M, LLC."}],"balance_after":1349048,"source":{"system":"sec-edgar","filing":"0001213900-25-046977","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025046977/ownership.xml","form_type":"4"}},{"id":1137478,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T19:38:56.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":1796468,"price":2.7129,"value":4873638.0372,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"M33 Growth I GP LLC (\"M33 LLC\") is the general partner of M33 Growth I L.P. (\"M33 LP\") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":14624233,"source":{"system":"sec-edgar","filing":"0001213900-25-046977","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025046977/ownership.xml","form_type":"4"}},{"id":1188930,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Shares of Common Stock","published_at":"2025-03-28T19:36:47.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":1358449,"price":0.125,"value":169806.125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 26, 2025, pursuant to a Securities Purchase Agreement, dated March 24, 2025, M33 Growth I LP (\"M33 LP\") purchased an aggregate of 1,358,449 units (\"Units\") consisting of 2,716,898 shares of common stock and 1,358,449 warrants (\"Warrants\") to purchase shares of common stock for an exercise price of $1.1980 per share. M33 acquired the Units for a price per Unit of $2.2084 (an aggregate purchase price of $2,999,998.77), with a cost per share of common stock of $1.0417 and a cost per Warrant of $0.1250. The Warrants are not exercisable to the extent that the exercise thereof would cause the reporting person to beneficially own greater than 19.99% of the outstanding shares of common stock of the Issuer. The purchase of the Units was approved by the Issuer's Board of Directors in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"M33 Growth I GP LLC (\"M33 LLC\") is the general partner of M33 LP (\"M33 GP\") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":1358449,"derivative":{"exercise_price":1.198,"exercise_date":"2025-03-26","expiration_date":"2030-03-26","underlying":"Common Stock","underlying_shares":1358449},"source":{"system":"sec-edgar","filing":"0001013762-25-004330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000101376225004330/ownership.xml","form_type":"4"}},{"id":1188929,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-28T19:36:47.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":2716898,"price":1.0417,"value":2830192.6466,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 26, 2025, pursuant to a Securities Purchase Agreement, dated March 24, 2025, M33 Growth I LP (\"M33 LP\") purchased an aggregate of 1,358,449 units (\"Units\") consisting of 2,716,898 shares of common stock and 1,358,449 warrants (\"Warrants\") to purchase shares of common stock for an exercise price of $1.1980 per share. M33 acquired the Units for a price per Unit of $2.2084 (an aggregate purchase price of $2,999,998.77), with a cost per share of common stock of $1.0417 and a cost per Warrant of $0.1250. The Warrants are not exercisable to the extent that the exercise thereof would cause the reporting person to beneficially own greater than 19.99% of the outstanding shares of common stock of the Issuer. The purchase of the Units was approved by the Issuer's Board of Directors in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"M33 Growth I GP LLC (\"M33 LLC\") is the general partner of M33 LP (\"M33 GP\") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":16420701,"source":{"system":"sec-edgar","filing":"0001013762-25-004330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000101376225004330/ownership.xml","form_type":"4"}}]}